RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery

• Status: Recruiting
• Trial end date: 2024-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Remimazolam besylate, as a new benzodiazepine drug, has few advantages in respiratory depression and gastrointestinal motility. The study will further explore the safety and effectiveness of remimazolam besylate n the sedation of mechanically ventilated patients after oral and maxillofacial surgery in the ICU

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nanfang Hospital of Southern Medical University
• Treatments: Midazolam; Propofol

Criteria

Inclusion Criteria:

• Age ≥18 years old

• mechanical ventilation patients with expected ICU stay time <72h

• People who need immediate sedative treatment

Exclusion Criteria:

• pregnancy；

• can not get RASS score from patients

• allergy to drugs